Quantcast
Last updated on April 16, 2014 at 17:34 EDT

LifeAgain Announces Recognition Of National Prostate Cancer Awareness Month

September 20, 2013

LifeAgain Launches BlueMetric Select Term Life Insurance – First Program Designed for Men with Active Localized Prostate Cancer

SAN DIEGO, Sept. 20, 2013 /PRNewswire/ — LifeAgain Insurance Solutions Inc., a wholly-owned subsidiary of Cardium Therapeutics (NYSE MKT: CXM), today announced its recognition of National Prostate Cancer Awareness Month. September 2013 has been declared National Prostate Awareness Month by Presidential Proclamation to “raise awareness, support research, improve care, and reduce the impact of this disease on our citizens and our Nation.”

(Logo: http://photos.prnewswire.com/prnh/20130919/LA82808LOGO)

Prostate cancer is the most common non-skin cancer in America, affecting 1 in 6 men. In 2013, more than 238,000 men will be diagnosed with prostate cancer, and more than 30,000 men will die from the disease. It is estimated that over the next 10 years in the United States, approximately 8 million men under age 64 will be determined to have elevated PSA scores (prostate-specific antigen) without formal determination of prostate cancer, and 1 million men under age 64 will be diagnosed with prostate cancer. Overall, 1.6 million men have elevated PSA, and about 30 percent of them will be diagnosed with prostate cancer.

Currently, men with elevated prostate-specific antigen (PSA) scores and active localized prostate cancer usually are considered uninsurable based on traditional life insurance underwriting standards. Pioneering this field, LifeAgain recently introduced the first term life insurance for men with active localized prostate cancer. LifeAgain’s BlueMetric Select(TM) program was specifically designed to assist life insurance companies to provide eligible men with term life insurance coverage following a cancer diagnosis or upon the completion of a prostate cancer surgery, without the traditional multi-year waiting periods and additional medical re-qualifications generally required by most life insurance companies. Importantly, it is available to prostate cancer patients who are in a “watchful waiting” treatment plan, including younger men who traditionally have been denied life insurance with few exceptions. The BlueMetric Select program was developed based on LifeAgain’s Advanced Medical Data Analytics Platform Technology (ADAPT(TM)). Additional information about the BlueMetric Select Program is available at www.lifeagain.com.

About LifeAgain

LifeAgain Insurance Solutions, Inc. is an advanced medical data analytics business and life insurance agency that is focused on the development, marketing and sale of “survivable risk” term life insurance programs for cancer survivors or others with medical conditions who are currently considered uninsurable based on traditional underwriting standards. Working in cooperation with large and established life insurance companies, LifeAgain uses new actuarial methods, and scientific and medical data-driven insights to design life insurance solutions for those who may otherwise not be able to obtain coverage. LifeAgain’s initial focus is on the development, marketing and sale of survivable risk life insurance for men with active localized prostate cancer. LifeAgain plans to develop additional new and innovative life insurance solutions for men and women with other medical conditions. Additional information is available at www.lifeagain.com.

Forward-Looking Statements

This press release includes statements that look forward in time or that express management’s beliefs, expectations or hopes. Such statements are necessarily based on estimates and assumptions that are inherently subject to significant business, economic, and competitive uncertainties and contingencies, many of which are beyond our control and subject to change. Moreover, we operate in a rapidly changing and competitive environment. These uncertainties and contingencies could cause actual results to differ materially from those expressed, and therefore undue reliance should not be placed upon such statements. The Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this report.

LifeAgain Insurance Solutions Inc. is a life insurance agency incorporated in Delaware and registered in New York as LifeAgain Insurance Services. Insurance issued under the BlueMetric Select program may not be available in all states.

For the education of Producers and Brokers Only – not for public use.

Copyright 2013 LifeAgain Insurance Solutions Inc. All rights reserved.
For Terms of Use Privacy Policy, please visitwww.lifeagain.com.

LifeAgain(®), BlueMetric Select(TM), Decision Rule Adaption(TM), and ADAPT(TM) are trademarks of
LifeAgain Insurance Solutions Inc. or Cardium Therapeutics, Inc.
Other trademarks belong to their respective owners.

SOURCE LifeAgain; Cardium Therapeutics


Source: PR Newswire